These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 20380807)
41. Mutational analysis of the Smad6 and Smad7 genes in hepatocellular carcinoma. Kawate S; Ohwada S; Hamada K; Koyama T; Takenoshita S; Morishita Y; Hagiwara K Int J Mol Med; 2001 Jul; 8(1):49-52. PubMed ID: 11408948 [TBL] [Abstract][Full Text] [Related]
42. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Midorikawa Y; Yamamoto S; Ishikawa S; Kamimura N; Igarashi H; Sugimura H; Makuuchi M; Aburatani H Oncogene; 2006 Sep; 25(40):5581-90. PubMed ID: 16785998 [TBL] [Abstract][Full Text] [Related]
43. Analysis of loss of heterozygosity on chromosome 4q in hepatocellular carcinoma using high-throughput SNP array. Zhang H; Ma H; Wang Q; Chen M; Weng D; Wang H; Zhou J; Li Y; Sun J; Chen Y; Liang X; Zhao J; Pan K; Wang H; Xia J Oncol Rep; 2010 Feb; 23(2):445-55. PubMed ID: 20043106 [TBL] [Abstract][Full Text] [Related]
44. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene. Ho SY; Wang YJ; Chen HL; Chen CH; Chang CJ; Wang PJ; Chen HH; Guo HR Cancer Causes Control; 2004 Sep; 15(7):657-63. PubMed ID: 15280623 [TBL] [Abstract][Full Text] [Related]
46. Interaction between interleukin-1beta -31T/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese. Sakamoto T; Higaki Y; Hara M; Ichiba M; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Tanaka K Cancer Lett; 2008 Nov; 271(1):98-104. PubMed ID: 18603357 [TBL] [Abstract][Full Text] [Related]
47. Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver disease. Falleti E; Fabris C; Toniutto P; Fontanini E; Cussigh A; Bitetto D; Fumolo E; Fornasiere E; Bragagnini W; Pinato DJ; Minisini R; Pirisi M Oncology; 2009; 77(5):304-13. PubMed ID: 19940521 [TBL] [Abstract][Full Text] [Related]
48. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900 [TBL] [Abstract][Full Text] [Related]
49. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Xu T; Zhu Y; Wei QK; Yuan Y; Zhou F; Ge YY; Yang JR; Su H; Zhuang SM Carcinogenesis; 2008 Nov; 29(11):2126-31. PubMed ID: 18711148 [TBL] [Abstract][Full Text] [Related]
50. MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation. Wu L; Xu X; Shen J; Xie H; Yu S; Liang T; Wang W; Shen Y; Zhang M; Zheng S J Surg Oncol; 2007 Jul; 96(1):62-8. PubMed ID: 17443726 [TBL] [Abstract][Full Text] [Related]
51. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection. Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781 [TBL] [Abstract][Full Text] [Related]
52. Polymorphism of T-cell receptor gamma short tandem repeats as a susceptibility risk factor of hepatocellular carcinoma. Hsu LM; Huang YS; Yang SY; Chang FY; Lee SD Anticancer Res; 2006; 26(5B):3787-91. PubMed ID: 17094402 [TBL] [Abstract][Full Text] [Related]
53. [Study on the relationship between hepatocellular carcinoma and the interaction between polymorphisms in DNA repair gene XPD and environmental factors]. Zeng XY; Qiu XQ; Ji L; Yu HP Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jul; 30(7):702-5. PubMed ID: 19957595 [TBL] [Abstract][Full Text] [Related]
54. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. McGlynn KA; Hunter K; LeVoyer T; Roush J; Wise P; Michielli RA; Shen FM; Evans AA; London WT; Buetow KH Cancer Res; 2003 Aug; 63(15):4594-601. PubMed ID: 12907637 [TBL] [Abstract][Full Text] [Related]
55. Two variants of the human hepatocellular carcinoma-associated HCAP1 gene and their effect on the growth of the human liver cancer cell line Hep3B. Wan D; He M; Wang J; Qiu X; Zhou W; Luo Z; Chen J; Gu J Genes Chromosomes Cancer; 2004 Jan; 39(1):48-58. PubMed ID: 14603441 [TBL] [Abstract][Full Text] [Related]
56. Pin1 promoter polymorphisms in hepatocellular carcinoma patients. Segat L; Milanese M; Crovella S Gastroenterology; 2007 Jun; 132(7):2618-9; author reply 2619-20. PubMed ID: 17570241 [No Abstract] [Full Text] [Related]